Publications by authors named "D S Bug"

The adenomas in Cushing's disease frequently exhibit mutations in exon 14, within a binding motif for the regulatory protein 14-3-3 located between the catalytic domain (DUB), responsible for ubiquitin hydrolysis, and the WW-like domain that mediates autoinhibition, resulting in constantly active USP8. The exact molecular mechanism of deubiquitinase activity disruption in Cushing's disease remains unclear. To address this, Sanger sequencing of was performed to identify mutations in corticotropinomas.

View Article and Find Full Text PDF

The Dicer protein is an indispensable player in such fundamental cell pathways as miRNA biogenesis and regulation of protein expression in a cell. Most recently, both germline and somatic mutations in have been identified in diverse types of cancers, which suggests Dicer mutations can lead to cancer progression. In addition to well-known hotspot mutations in RNAase III domains, is characterized by a wide spectrum of variants in all the functional domains; most are of uncertain significance and unstated clinical effects.

View Article and Find Full Text PDF
Article Synopsis
  • Dose-intensive therapies during allogeneic hematopoietic stem cell transplantation (allo-HSCT) significantly disrupt gut microbiota and promote antibiotic resistance, with recovery patterns poorly understood.
  • In a study of 12 adult patients, stool samples revealed a marked decline in microbial diversity starting from day 0, persisting for up to a year, with specific bacterial genera showing slower recovery.
  • A rise in antibiotic-resistant bacteria was observed around day 30 post-transplant, with resistance to major antibiotic classes, but a gradual decrease in resistance levels was noted over the following year.
View Article and Find Full Text PDF
Article Synopsis
  • A pilot clinical study showed that oral microbiota transplantation from a healthy mother to her 6-month-old child with neuroblastoma can safely prevent chemotherapy-induced oral mucositis.
  • The patient received oral donor saliva during chemotherapy cycles, which led to a significant reduction in the severity of oral mucositis, only experiencing mild symptoms after hematopoietic cell transplantation.
  • The study also revealed changes in the patient's oral bacteria, with an increase in beneficial bacteria and a decrease in harmful strains, and no adverse effects from the transplantation were reported.
View Article and Find Full Text PDF